MindMatters White Logo

BT5K Your Way: Flexible Virtual Fundraising

Share This Content:


The ABTA’s largest nationwide fundraiser, Breakthrough for Brain Tumors 5K (BT5K) Run & Walk events, are moving to more flexible programming, where anyone, anywhere can participate. This customizable fundraising event allows the ABTA to focus on the health and safety of the brain tumor community and meet local city and state guidelines due the impact of the coronavirus. Personalized participation in the 5K events help raise necessary funds to support brain tumor research and patient programs and services.

Nationwide BT5K: It’s Your Choice

Walk, run, bike, push a stroller or even rollerblade for 5 kilometers on your own time. From September 5 through September 13, participants can select the route, mode of completing the 5K and track their own distance. Participants can get moving as soon as they register

All registered adults receive a BT5K dri-fit shirt, race bib and finishers certificate. Registered children, ages 2 – 16, will also get a finisher’s medal.

Mark your calendars for Sunday, September 13! A virtual celebration will take place with a live online event, including opening ceremonies, speakers, giveaways and much more.

Planned In-Person and Virtual Events

In addition to the national BT5K held in September, five local BT5K events are planned for October and November. All city-specific 5K events have the opportunity to participate virtually. 

If you are interested in joining the following city-specific BT5Ks, contact the ABTA at events@abta.org or visit BT5K Your Way.


Save the Date!

Sunday, October 4

Virtual Event
Virtual Event

Saturday, October 10

Twin Cities
In-Person and Virtual Event

In Person Event Virtual Event

Sunday, October 18

Los Angeles
In-Person and Virtual Event
In Person Event

Virtual Event

Sunday, November 1

San Francisco
In-Person and Virtual Event
In Person EventVirtual Event

Sunday, November 8

New York City
In-Person and Virtual Event

In Person EventVirtual Event


Join us and help support brain tumor breakthroughs on the cusp of discovery and provide patients and families with vital programs.